Trial Profile
Treatment of extraesophageal manifestations of laryngopharyngeal reflux with Nexium (esomeprazole) 20mg bid, a doubleblind placebo controlled study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2011
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary)
- Indications Laryngopharyngeal reflux
- Focus Therapeutic Use
- 18 May 2011 New trial record